Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

NCT06266091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Ascites

Interventions

DRUG: M701
DRUG: paracentesis

Sponsor

Wuhan YZY Biopharma Co., Ltd.